Skip to main content Back to Top
Advertisement

10/4/2019

Tacrolimus Capsules

Products Affected - Description

    • Prograf oral capsule, Astellas, 0.5 mg, 100 count, NDC 00469-0607-73
    • Prograf oral capsule, Astellas, 1 mg, 100 count, NDC 00469-0617-73
    • Prograf oral capsule, Astellas, 1 mg, unit-dose 100 count, NDC 00469-0617-11
    • Prograf oral capsule, Astellas, 5 mg, 100 count, NDC 00469-0657-73
    • Prograf oral capsule, Astellas, 5 mg, unit-dose 100 count, NDC 00469-0657-11
    • Tacrolimus oral capsule, Accord, 0.5 mg, 100 count, NDC 16729-0041-01
    • Tacrolimus oral capsule, Accord, 1 mg, 100 count, NDC 16729-0042-01
    • Tacrolimus oral capsule, Accord, 5 mg, 100 count, NDC 16729-0043-01
    • Tacrolimus oral capsule, Bionpharma, 0.5 mg, 100 count, NDC 69452-0153-20
    • Tacrolimus oral capsule, Bionpharma, 1 mg, 100 count, NDC 69452-0154-20
    • Tacrolimus oral capsule, Bionpharma, 5 mg, 100 count, NDC 69452-0155-20
    • Tacrolimus oral capsule, Major, 0.5 mg, unit-dose blister pack, 100 count, NDC 00904-6623-61
    • Tacrolimus oral capsule, Major, 1 mg, unit-dose blister pack, 100 count, NDC 00904-6625-61
    • Tacrolimus oral capsule, Major, 5 mg, unit-dose blister pack, 100 count, NDC 00904-6624-61
    • Tacrolimus oral capsule, Strides Pharma, 1 mg, 100 count, NDC 64380-0721-06

Reason for the Shortage

    • Accord has tacrolimus on temporary discontinuation due to raw ingredient shortage.
    • Astellas has Prograf on allocation.
    • Bionpharma did not provide a reason for the shortage.
    • Lannett has discontinued tacrolimus capsules.
    • Major did not provide a reason for the shortage.
    • Mylan refuses to provide availability information.
    • Sandoz has tacrolimus available.

Available Products

    • Tacrolimus oral capsule, Sandoz, 0.5 mg, 100 count, NDC 00781-2102-01
    • Tacrolimus oral capsule, Sandoz, 1 mg, 100 count, NDC 00781-2103-01
    • Tacrolimus oral capsule, Sandoz, 5 mg, 100 count, NDC 00781-2104-01

Estimated Resupply Dates

    • Accord has tacrolimus 0.5 mg, 1 mg, and 5 mg capsules on temporary discontinuation and the company cannot estimate a release date.
    • Astellas has Prograf capsules on allocation.
    • Bionpharma has tacrolimus 0.5 mg, 1 mg, and 5 mg capsules on back order and the company cannot estimate a release date.
    • Major has tacrolimus 0.5 mg, 1 mg, and 5 mg capsules on back order and the company cannot estimate a release date.
    • Strides has tacrolimus 1 mg capsules on allocation.

Updated

Updated October 4, 2019 by Rachael Freeman, PharmD, BCPS. Created June 4, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins